However, some studies do identify an increased risk of breast cancer incidence, and younger age at diagnosis in women with germline variants in PMS2 and MSH6, but no association with germline mutations in MLH1 or MSH2 [54, 55]. This evidence concerns the gene PMS2 and breast carcinoma.